Developments in avian influenza virus vaccines

Journal of Poultry Science

Volumn 44, Issue 3, 2007, Pages 238-257

  Collisson, Ellen W ^a,b   Singh, Shailbala ^b   Omran, Mohamad Tawfik ^b  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Attenuated; Avian influenza virus; Inactivated; Recombinant; Vaccines

Indexed keywords

AVES; AVIAN INFLUENZA VIRUS; FOWLPOX VIRUS; INFLUENZA A VIRUS; INFLUENZAVIRUS A; MAMMALIA; ORTHOMYXOVIRIDAE;

EID: 34547604105     PISSN: 13467395     EISSN: 13490486     Source Type: Journal    
DOI: 10.2141/jpsa.44.238     Document Type: Review

References (134)

1. Acsadi G, Jiao SS, Jani A, Duke D, Williams P, Chong W and Wolff JA. Direct gene transfer and expression into rat heart in vivo. New Biologist, 3: 71-81. 1991.
2. Afonso CL, Tulman ER, Lu Z, Zsak L, Kutish GF and Rock DL. The genome of fowlpox virus. Journal of Virology, 74: 3815-3831. 2000.
3. Akarsu H, Burmeister WP, Petosa C, Petit I, Muller CW, Ruigrok RW and Baudin F. Crystal structure of the M 1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO Journal, 22: 4646-4655. 2003.
4. Alexander DJ. A review of avian influenza in different bird species. Veterinary Microbiology, 74: 3-13. 2000.
5. Allen WH, Madelye CR and Kenday AP. Studies with avian influenza A viruses: cross immunity. Journal of General Virology, 12: 79-84. 1971.
6. Allwright DM, Burger WP, Geyer A and Terblanche AW. Isolation of an avian influenza A virus from ostiches (Strutheo camelas) Avian Diseases, 22: 59-65. 1993.
7. Arzt S, Petit I, Burmeister WP, Ruigrok RW and Baudin F. Structure of a knockout mutant of influenza virus M1 protein that has altered activities in membrane binding, oligomerisation and binding to NEP (NS2). Virus Research, 99: 115-119. 2004.
8. Aymard-Henry M CM, Dowdle WR, Laver WG, Schild GC and Webster RG. Influenza virus neuraminidase and neuraminidase-inhibition test procedure. Bulletin of the World Health Organization, 48: 199-202. 1973.
9. Bagust TJ. Laryngotracheitis (Gallid-1) herpesvirus infection in the chicken. 4. Latency establishment by wild and vaccine strains of ILT virus. Avian Pathology, 15: 581-595. 1986.
10. Bagust TJ, Jones RC and Guy JS. Avian infectious laryngotracheitis. Revue Scientifique et Technique, 19: 483-492. 2000.
11. Beard CW, Schnitzlein WM and Tripathy DN. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses. Avian Diseases, 35: 356-359. 1991.
12. Beard CW, Schnitzlein WM and Tripathy DN. Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza. Avian Diseases, 36: 1052-1055. 1992.
13. Benvenisty N and Reshef L. Direct Introduction of genes into rats and expression of the gene. Proceedings of the National Academy of Sciences of the United States of America, 83: 9551-9555. 1986.
14. Bosch FX, Garten W, Klenk HD and Rott R. Proteolytic cleavage of influenza virus hemagglutinins: primary structure of the connecting peptide between HA1 and HA2 determines proteolytic cleavability and pathogenicity of Avian influenza viruses. Virology, 113: 725-735. 1981.
15. Boyle DB, P. S and Heine HG. Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin. Australian Veterinary Journal, 78: 44-48. 2000.
16. Brown JD, Stallknecht DE, Beck JR, Suarez DL and Swayne DE. Susceptibility of North American ducks and gulls to H5N1 highly pathogenic avian influenza viruses. Emerging Infectious Diseases, 12: 1663-1670. 2006.
17. Brugh M. Re-examination of pathogenicity, virulence and lethality. In: Proceedings of the fourth international symposium on avian influenza. (Swayne DE and Slemons RD, eds.) U.S. Animal Health Association, Athens, GA, pp. 129-132.1997.
18. Brugh M, Beard CW and Stone HD. Immunization of chickens and turkeys against avian influenza with monovalent and polyvalent oil emulsion vaccines. American Journal of Veterinary Research, 40: 165-169. 1979.
19. Bublot M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, Audonnet JC and Mickle TR. Development and use of fowlpox vectored vaccines for avian influenza. Annals of the New York Academy of Sciences, 1081: 193-201. 2006.
20. Butt KM, Smith GJ, Chen H, Zhang LJ, Leung YH, Xu KM, Lim W, Webster RG, Yuen KY, Peiris JS and Guan Y. Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. Journal of Clinical Microbiology, 43: 5760-5767. 2005.
21. Butterfield WK and Campbell CH. Vaccination of chickens with influenza A/Turkey/Oregon/71 virus and immunity challenge exposure to five strains of fowl plague virus. Proceedings, Annual Meeting of the United States Animal Health Association: 320-324. 1978.
22. Capua I and Alexander DJ. The challenge of avian influenza to the veterinary community. Avian Pathology, 35: 189 -205. 2006.
23. Cardona CJ, Charlton BR and Woolcock PR. Persistence of immunity in commercial egg-laying hens following vaccination with a killed H6N2 avian influenza vaccine. Avian Diseases, 50: 374-379. 2006.
24. Carr CM, Chaudhry C and Kim PS. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proceedings of the National Academy of Sciences of the United States of America, 94: 14306-14313. 1997.
25. Casais R, Davies M, Cavanagh D and Britton P. Gene 5 of the avian coronavirus infectious bronchitis virus is not essential for replication. Journal of Virology, 79: 8065-8078. 2005.
26. Chu RS, Targoni OS, Krieg AM, Lehmann PV and Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. Journal of Experimental Medicine, 186: 1623-1631. 1997.
27. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Serine DA, Krauss S, Shortridge KF and Webster RG. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet, 351: 472-477. 1998.
28. Collisson EW, Pei J, Dzielawa J and Seo SH. Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry. Developmental and Comparative Immunology, 24: 187-200. 2000.
29. Crawford J, Wilkinson B, Vosnesensky A, Smith G, Garcia M, Stone H and Perdue ML. Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine, 17: 2265-2274. 1999.
30. Crawford JM, Garcia M, Stone H, Swayne D, Slemons R and Perdue ML. Molecular characterization of the hemagglutinin gene and oral immunization with a water-fowl-origin avian influenza virus. Avian Diseases, 42: 486-496. 1998.
31. Deck RR, DeWitt CM, Donnelly JJ, Liu MA and Ulmer JB. Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine. Vaccine, 15: 71-78. 1997.
32. Desselberger U, Nakajima K, Alfino P, Pedersen FS, Haseltine WA, Hannoun C and Palese P. Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proceedings of the National Academy of Sciences of the United States of America, 75: 3341-3345. 1978.
33. Donahoe JP. Inactivated avian infuenza whole virus vaccines. In: Proceedings of the Fourth International Symposium on Avian Influenza. (Swayne DE SR, ed.) Rose Printing Company, Athens, Georgia, 1997.
34. +-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. Journal of Biological Chemistry, 271: 13417-13421. 1996.
35. Fahey KJ, York JJ and Bagust TJ. Laryngotracheitis herpesviruses infection in the chicken. II. The adoptive transfer of resistance with immune spleen cells. Avian Pathology, 13: 265-275. 1984.
36. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, Smith D, Rimmelzwaan GF, Olsen B and Osterhaus AD. Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls. Journal of Virology, 79: 2814-2822. 2005.
37. Frace AM, Klimov AI, Rowe T, Black RA and Katz JM. Modified M2 proteins produce heterotypic immunity against influenza A virus. Vaccine, 17: 2237-2244. 1999.
38. Fuchs W, Ziemann K, Teifke JP, Werner O and Mettenleiter TC. The non-essential UL50 gene of avian infectious laryngotracheitis virus encodes a functional dUTPase which is not a virulence factor. Journal of General Virology, 81: 627-638. 2000.
39. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC and Robinson HL. DNA vaccines: a novel approach to immunization. International Journal of Immunopharmacology, 17: 79-83. 1995.
40. Gao W, Soloff AC, Lu X, Montecalvo A, Nguyen DC, Matsuoka Y, Robbins PD, Swayne DE, Donis RO, Katz JM, Barratt-Boyes SM and Gambotto A. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. Journal of Virology, 80: 1959-1964. 2006.
41. Garcia M, Crawford JM, Latimer JW, Rivera-Cruz E and Perdue ML. Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico. Journal of General Virology, 77: 1493-1504. 1996.
42. Garcia-Garcia J HR, Alejandro HM. Experimental studies and field trials with recombinant fowpox vaccine to broilders in Mexico. In: Proceedings of the fourth international conference on avian influenza. (Swayne DE SR, ed.) Rose Printing Company, Athens, Georgia, 1997.
43. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P and Musler T. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology, 252: 324-330. 1998.
44. Garten W, Bosch FX, Linder D, Rott R and Klenk HD. Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. Virology, 115: 361-374. 1981.
45. Halvorson DA: Strengths and weaknesses of vaccines as a control tool. In: Fourth international symposium of avian influenza, Athens, GA, pp. 223-227. 1997.
46. Hayashida H, Toh H, Kikuno R and Miyata T. Evolution of influenza virus genes. Molecular Biology and Evolution, 2: 289-303. 1985.
47. Heeg K and Zimmermarm S. CpG DNA as a Th1 trigger. International Archives of Allergy and Immunology, 121: 87-97. 2000.
48. Hoffmann E, Neumann G, Kawaoka Y, Hobom G and Webster RG. A DNA transfection system for generation of influenza A virus from eight plasmids. Proceedings of the National Academy of Sciences of the United States of America, 97: 6108-6113. 2000.
49. Holland J, Spindler K, Horodyski F, Grabau E, Nichol S and VandePol S. Rapid evolution of RNA genomes. Science, 215: 1577-1585. 1982.
50. Hooper P and Selleck P: Pathology of low and high virulent influenza virus infections. In: Fourth international symposium on avian influenza, Athens, Georgia, pp. 134-161. 1997.
51. Hsieh MK, Wu CC and Lin TL. The effect of co-administration of DNA carrying chicken interferon-gamma gene on protection of chickens against infectious bursal disease by DNA-mediated vaccination. Vaccine, 24: 6955-6965. 2006.
52. Inglis SC and Almond JW. An influenza virus gene encoding two different proteins. Philosophical transactions of the Royal Society of London. Series B, Biological Sciences, 288: 375-381. 1980.
53. Karunakaran D, Newman JA, Halvorson DA and Abraham A. Evaluation of inactivated influenza vaccines in market turkeys. Avian Diseases, 31: 498-503. 1987.
54. Kim CH, Macosko JC and Shin YK. The mechanism for low-pH-induced clustering of phospholipid vesicles carrying the HA2 ectodomain of influenza hemagglutinin. Biochemistry, 37: 137-144. 1998.
55. Kim SJ, Sung HW, Han JH, Jackwood D and Kwon HM. Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines. Veterinary Microbiology, 101: 39-51. 2004.
56. Kodihalli S, Kobasa DL and Webster RG. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine, 18: 2592-2599. 2000.
57. Kodihalli S, Sivanandan V, Nagaraja KV, Shaw D and Halvorson DA. A type-specific avian influenza virus subunit vaccine for turkeys: induction of protective immunity to challenge infection. Vaccine, 12: 1467-1472. 1994.
58. Krug RM, Broni BA and Bouloy M. Are the 5′ ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell, 18: 329-334. 1979.
59. Kuwano K, Scott M, Young JF and Ennis FA. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. Journal of Immunology, 140: 1264-1268. 1988.
60. Lamb RA and Choppin PW. Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology, 112: 729-737. 1981.
61. Lamb RA and Krug RM. Orthomyxoviridae: The viruses and their replication. In: Fundamental virology. (Knipe DM HP, Grifline DE, Lamb RA, Marin MA, Roizman R, Straus SE, ed.) pp. 725-769. Lippincott Williams & Willins, 2001.
62. Lamb RA, Lai CJ and Choppin PW. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proceedings of the National Academy of Sciences of the United States of America, 78: 4170-4174. 1981.
63. Lee CW, Senne DA and Suarez DL. Development and application of reference antisera against 15 hemagglutinin subtypes of infeluenza virus by DNA vaccination of chickens. Clinical and Vaccine Immunology, 13: 395-402. 2006.
64. Lee CW, Senne DA and Suarez DL. Development and application of reference antisera against 15 hemagglutinin subtypes of infeluenza virus by DNA vaccination of chickens. Clinical and Vaccine Immunology, 13: 395-402. 2006.
65. Li J, Huang Y, Liang X, Lu M, Li L, Yu L and Deng R. Plasmid DNA encoding antigens of infectious bursal disease viruses induce protective immune responses in chickens: factors influencing efficacy. Virus Research, 98: 63-74. 2003.
66. Li Z, Jiang Y, Jiao P, Wang A, Zhao F, Tian G, Wang X, Yu K, Bu Z and Chen H. The NS1 gene contributes to the virulence of H5N1 avian influenza viruses. Journal of Virology , 80: 11115-11123. 2006.
67. Lillehoj HS, Ding X, Quiroz MA, Bevensee E and Lillehoj EP. Resistance to intestinal coccidiosis following DNA immunization with the cloned 3-1E Eimeria gene plus IL-2, IL-15, and IFN-gamma. Avian Diseases, 49: 112-117. 2005.
68. Lin YP, Shaw M, Gregory V, Cameron K, Lim W, Klimov A, Subbarao K, Guan Y, Krauss S, Shortridge K, Webster R, Cox N and Hay A. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proceedings of the National Academy of Sciences of the United States of America, 97: 9654-9658. 2000.
69. Livingston BD, Higgins D and Van Nest G. Evolving strategies for the prevention of influenza infection: potential for multistrain targeting. BioDrugs, 20: 335-340. 2006.
70. Luneberg J, Martin I, Nussler F, Ruysschaert JM and Herrmann A. Structure and topology of the influenza virus fusion peptide in lipid bilayers. Journal of Biological Chemistry, 270: 27606-27614. 1995.
71. Luschow D, Werner O, Mettenleiter TC and Fuchs W. Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine, 19: 4249-4259. 2001.
72. Luytjes W, Krystal M, Enami M, Pavin JD and Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell, 59: 1107-1113. 1989.
73. Mahmood MS, Siddique M, Hussain I, Khan A and Mansoor MK. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Vaccine, 24: 4838-4846. 2006.
74. Manders P and Thomas R. Immunology of DNA vaccines: CpG motifs and antigen presentation. Inflammation Research, 49: 199-205. 2000.
75. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA and Klenk HD. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. Journal of Virology, 78: 12665-12667. 2004.
76. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA and Klenk HD. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proceedings of the National Academy of Sciences of the United States of America, 101: 4620-4624. 2004.
77. McCauley JW, Mahy BW and Inglis SC. Nucleotide sequence of fowl plague virus RNA segment 7. Journal of General Virology, 58: 211-215. 1982.
78. McFerran JB and Smyth JA. Avian adenoviruses. Revue Scientifique et Technique, 19: 589-601. 2000.
79. McNulty MS, Allan GM and Adair GM. Efficacy of avian influenza neuraminidase specific vaccines in chickens. Avian Pathology, 15: 107-115. 1986.
80. Mingxiao M, Ningyi J, Zhenguo W, Ruilin W, Dongliang F, Min Z, Gefen Y, Chang L, Leili J, Kuoshi J and Yingjiu Z. Construction and immunogenicity of recombinant fowpox vaccines coexpressing HA of AIV H5N1 and chicken IL18. Vaccine, 24: 4304-4311. 2006.
81. + T cells using VP22 DNA vaccine vectors that promote intercellular spreading following initial transfection. Journal of Leukocyte Biology, 78: 401-411. 2005.
82. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, Wong MP, Chui WH, Poon LL, Tsao SW, Guan Y and Peiris JS. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature Medicine, 13: 147-149. 2007.
83. O'Donnell LA, Clemmer JA, Czymmek K and Schmidt CJ. Marek's disease virus VP22: subcellular localization and characterization of carboxyl terminal deletion Mutations. Virology, 292: 235-240. 2002.
84. Ohuchi M, Asaoka N, Sakai T and Ohuchi R. Roles of neuraminidase in the initial stage of influenza virus infection. Microbes and Infection, 8: 1287-1293. 2006.
85. Ohuchi M, Orlich M, Ohuchi R, Simpson BE, Garten W, Klenk HD and Rott R. Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2). Virology, 168: 274-280. 1989.
86. Oliveira SC, Harms JS, Afonso RR and Splitter GA. A genetic immunization adjuvant system based on BVP22-antigen fusion. Human Gene Therapy, 12: 1353-1359. 2001.
87. Olsen B, Munster VJ, Wallensten A, Waldenstrom J, Osterhaus AD and Fouchier RA. Global patterns of influenza a virus in wild birds. Science, 312: 384-388. 2006.
88. O'Neill RE, Talon J and Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of the viral ribonucleoproteins. EMBO Journal, 17: 288-295. 1998.
89. Organization WH. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. 6 February 2007.
90. Palese P and Compans RW. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. Journal of General Virology, 33: 159-163. 1976.
91. Palese P, Tobita K, Ueda M and Compans RW. Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology, 61: 397-410. 1974.
92. Panigrahy B, Seen DA and Pearson JE. Subtypes of avian infuenza virus (AIV) isolated from exotic passerine and psittacine birds, 1982-1991. In: Third International Symposium on Avian Influenza, Madison, WI, pp. 258-268. 1992.
93. Park MS, Steel J, Garcia-Sastre A, Swayne D and Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proceedings of the National Academy of Sciences of the United States of America, 103: 8203-8208. 2006.
94. Pastoret PP and Vanderplasschen A. Poxviruses as vaccine vectors. Comparative Immunology, Microbiology and Infectious Diseases, 26: 343-355. 2003.
95. Pei J, Briles WE and Collisson EW. Memory T cells protect chicks from acute infectious bronchitis virus infection. Virology, 306: 376-384. 2003.
96. Perdue ML, Garcia M, Beck J, Brugh M and Swayne DE. An Arg-Lys insertion at the hemagglutinin cleavage site of an H5N2 avian influenza isolate. Virus Genes, 12: 77-84. 1996.
97. Perdue ML, Garcia M, Senne D and Fraire M. Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses. Virus Research, 49: 173-186. 1997.
98. Pisetsky DS. Immune activation by bacterial DNA: a new genetic code. Immunity, 5: 303-310. 1996.
99. Richman DD, Murphy BR, Belshe RB, Rusten HM, Chanock RM, Blacklow NR, Parrino TA, Rose FB, Levine MM and Caplan E. Temperature-sensitive mutants of influenza A virus. XIV. Production and evaluation of influenza A/Georgia/74-ts-1 [E] recombinant viruses in human adults. Journal of Infectious Diseases, 136: 256-262. 1977.
100. Roh HJ, Sung HW and Kwon HM. Effects of DDA, CpG-ODN, and plasmid-encoded chicken IFN-gamma on protective immunity by a DNA vaccine against IBDV in chickens. Journal of Veterinary Science, 7: 361-368. 2006.
101. Rott R, Becht H and Orlich M. The significance of influenza virus neuraminidase in immunity. Virology, 22: 35-41. 1974.
102. Saha S, Yoshida S, Ohba K, Matsui K, Matsuda T, Takeshita F, Umeda K, Tamura Y, Okuda K, Klinman D, Xin KQ and Okuda K. A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus. Virology, 354: 48-57. 2006.
103. Seo SH and Collisson EW. Specific cytotoxic T lymphocytes are involved in in vivo clearance of infectious bronchitis virus. Journal of Virology , 71: 5173-5177. 1997.
104. Seo SH, Pei J, Briles WE, Dzielawa J and Collisson EW. Adoptive transfer of infectious bronchitis virus primed alphabeta T cells bearing CD8 antigen protects chicks from acute infection. Virology, 269: 183-189. 2000.
105. Seo SH, Wang L, Smith R and Collisson EW. The carboxyl-terminal 120-residue polypeptide of infectious bronchitis virus nucleocapsid induces cytotoxic T lymphocytes and protects chickens from acute infection. Journal of Virology, 71: 7889-7894. 1997.
106. Seo SH and Webster RG. Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. Journal of Virology , 75: 2516-2525. 2001.
107. Shortridge K. Poultry and the influenza H5N1 outbreaks in Hong Kong, 1997. Abridged chronology and virus isolation. Vaccine, 17: S26-S29. 1999.
108. Skinner MA, Laidlaw SM, Eldaghayes I, Kaiser P and Cottingham MG Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry. Expert Review of Vaccines, 4: 63-76. 2005.
109. Slemons RD and Easterday BC. Type-A influenza viruses in the feces of migratory waterfowl. Journal of the American Veterinary Medical Association, 171: 947-948. 1977.
110. Slemons RD and Easterday BC. Virus replication in the digestive tract of ducks exposed by aerosol to type-A influenza. Avian Diseases, 22: 367-377. 1978.
111. Slemons RD, Johnson DC, Osborn JS and Hayes F. Type-A influenza viruses isolated from wild free-flying ducks in California. Avian Diseases, 18: 119-124. 1974.
112. Slepushkin VA, Katz JM, Black RA, Gamble WC, Rota PA and Cox NJ. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein. Vaccine, 13: 1399-1402. 1995.
113. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K and Cox N. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science, 279: 393-396. 1998.
114. Subbarao K and Shaw MW. Molecular aspects of avian influenza (H5N1) viruses isolated from humans. Reviews in Medical Virology, 10: 337-348. 2000.
115. Swayne DE, Beck JR and Mickle TR. Efficacy of recombinant fowlpox vaccine in protecting chickens against highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Diseases, 41: 335-346. 1997.
116. Swayne DE, Garcia M, Beck JR, Kinney N and Suarez DL. Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine, 18: 1088-1095. 2000.
117. Taylor J, Weinberg R, Kawaoka Y, Webster RG and Paoletti E. Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine, 6: 504-508. 1988.
118. Thacker EL, Fulton JE and Hunt HD. In vitro analysis of a primary, major histocompatibility complex (MHC)-restricted, cytotoxic T-lymphocyte response to avian leukosis virus (ALV), using target cells expressing MHC class I cDNA inserted into a recombinant ALV vector. Journal of Virology , 69: 6439-6444. 1995.
119. Thompson CI, Barclay WS, Zambon MC and Pickles RJ. Infection of human airway epithelium by human and avian strains of influenza a virus. Journal of Virology, 80: 8060-8068. 2006.
120. Toro H, Tang DC, Suarez DL, Sylte MJ, Pfeiffer J and Van Kampen KR. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine. 25: 2886-2891. 2007.
121. Tripathy DN and Schnitzlein WM. Expression of avian influenza virus hemagglutinin by recombinant fowlpox virus. Avian Diseases, 35: 186-191. 1991.
122. Uhner JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, DeWitt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL and Liu MA. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science, 259: 1745-1749. 1993.
123. Vey M, Orlick M, Adler S, Klenk HD, Rott R and Garten W. Hemagglutinin activation of pathogenic avian influenza viruses of serotype H7 requires the protease recognition motif R-X-K/R-R. Virology, 188: 408-413. 1992.
124. Weber S, Harder T, Starick E, Beer M, Werner O, Hoffmann B, Mettenleiter TC and Mundt E. Molecular analysis of highly pathogenic avian influenza virus of subtype H5N 1 isolated from wild birds and mammals in northern Germany. Journal of General Virology, 88: 554-558. 2007.
125. Webster RG, Bean WJ, Gorman OT, Chambers TM and Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiological Reviews, 56: 152-179. 1992.
126. Webster RG and Campbell CH. An inhibition test for identifying the neuraminidase antigen on influenza viruses. Avian Diseases, 16: 1057-1066. 1972.
127. Webster RG, Reay PA and Laver WG. Protection against lethal influenza virus with neuraminidase. Virology, 164: 230-237. 1988.
128. Wolff JA, Maloney RW, Williams P, Acsadi G, Jani A and Feigner PL. Direct gene transfer into mouse muscle in vivo. Science, 247: 1465-1468. 1990.
129. Wood JM, Kawaoka Y, Newberry LA, Bordwell E and Webster RG. Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/ Pennsylvania/1370/83 infection. Avian Diseases, 29: 867-872. 1985.
130. Wysocka M and Bennink JR. Limiting dilution analysis of memory cytotoxic T lymphocytes specific for individual influenza virus gene products. Cellular Immunology, 112: 425-429. 1988.
131. Yasuda J, Nakada S, Kato A, Toyoda T and Ishihama A. Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology, 196: 249-255. 1993.
132. Yates VJ, Rhee YO, Fry DE, El Mishad AM and McCormick KJ. The presence of avian adenoviruses and adenoassociated viruses in healthy chickens. Avian Diseases, 20: 146-152. 1976.
133. York JJ and Fahey KJ. Humoral and cell-mediated immune responses to the glycoproteins of infectious laryngotracheitis herpesvirus. Archives of Virology, 115: 289-297. 1990.
134. Youn S, Leibowitz JL and Collisson EW. In vitro assembled, recombinant infectious bronchitis viruses demonstrate that the 5a open reading frame is not essential for replication. Virology, 332: 206-215. 2005.